Ameruss Clinical Trials
United States of America
Pavel Shafranovskiy, PhD, MBA holds a doctorate in chemical physics in Russia and business master’s from the Open University of the United Kingdom, and is a principal shareholder in the SHAG Company. ZAO SHAG maintains eight distribution offices and 48 representatives in Russia for pharmaceuticals and durable medical products. Dr. Shafranovskiy is also General Director in the Impanta Group of companies focused on the distribution of cardiovascular implantable devices. Dr. Shafranovskiy maintains close working relationships with national thought leaders and health system directors throughout the regions.
Clinical Microbiology ,Molecular Biology , Pharmaceutical Chemistry,Pharmaceutical Analysis